查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2049135

子宮內避孕器（IUD）市場報告：按產品、應用和地區分類（2026-2034 年）

Intrauterine Devices (IUD) Market Report by Product (Hormonal Intrauterine Device, Copper Intrauterine Device), End-Use (Hospitals, Gynaecology Clinics, Community Healthcare, and Others), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球避孕器（IUD）市場規模達49億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到69億美元，2026年至2034年的複合年成長率（CAGR）為3.72%。推動市場成長的因素包括：人們對長效可逆避孕方法（LARC）的認知不斷提高、子宮內避孕器設計和植入技術的顯著進步，以及政府為促進計劃生育和避孕措施普及而採取的舉措。

避孕器（IUD）是一種長效、可逆的避孕方式，也是目前最有效的避孕方法之一。子宮內避孕器是一種小型T形裝置，由醫護人員放置於子宮內以防止懷孕。子宮內避孕器主要分為兩大類：一類是含銅子宮內避孕器，它會釋放少量銅來阻止精子與卵子結合；另一類是含激素子宮內避孕器，它會釋放激素來增稠子宮頸黏液，從而阻止精子與卵子結合。根據類型的不同，子宮內避孕器可提供3至10年的長期避孕保護。由於其有效性、可逆性和易用性，以及幾乎無需後續護理等優點，子宮內避孕器廣受歡迎。

全球市場成長的主要驅動力是人們對生殖健康意識的提高，而這得益於有效且長效避孕方法的廣泛普及。此外，人們對可逆且便捷的避孕方式的需求日益成長，也推動了市場成長。醫療專業人員和機構所進行的關於子宮內避孕器益處和用途的支持和宣傳活動也是市場成長的重要促進因素。同時，醫療專業人員因其安全性和可靠性而建議使用子宮內避孕器，這也促進了市場擴張。政府加強推廣計劃生育和生殖健康教育，也對市場產生了正面影響。最後，有利的醫療政策和保險覆蓋範圍，使得更多人能夠更方便、更經濟地使用子宮內避孕器，也推動了市場成長。

避孕器（IUD）市場的趨勢與促進因素

控制人口的努力日益增多

在永續意識日益增強的推動下，各國政府和國際組織正將人口控制措施列為優先事項。這一政策方向的重大轉變，強化了子宮內避孕器等有效且長效的避孕方法的作用。此外，各國政府機構、非政府組織和生產商之間開展的各類合作項目，旨在推廣子宮內避孕器作為推薦的計劃生育方法。這些合作計畫通常會促成大規模的宣傳活動、分銷網路和提高公眾意識的活動，使子宮內避孕器更容易被不同人群所接受和使用。此外，地方性介入措施和補貼計畫也進一步促進了子宮內避孕器的普及。這項強調負責任的計劃生育和生育選擇的全球人口控制趨勢，是推動子宮內避孕器市場需求和創新發展的強大動力。

女性勞動參與率的提高

女性勞動參與率的提高象徵文化和經濟的轉型，影響生活的各個層面，包括生育選擇。隨著女性不斷承擔職業角色，對便利、可靠且易於維護的避孕方式的需求日益成長。子宮內避孕器（IUD）以其長期有效性和極少的後續護理而著稱，符合職業女性的生活方式需求。子宮內避孕器為許多女性在平衡事業和個人生活時提供了所需的柔軟性和安心感。此外，雇主和醫療保健機構也越來越意識到這些需求，並將子宮內避孕器納入綜合健康保險福利，提供支援和保險報銷。市場供應與不斷成長的人口的實際需求相匹配，這不僅僅是一種趨勢，更是子宮內避孕器市場的重要驅動力。

醫療技術和研究的不斷進步

醫療產業的特點是醫療技術和研究的不斷進步，避孕領域也不例外。材料、設計和荷爾蒙釋放機制的創新正推動著更先進、更人性化的子宮內避孕器（IUD）的研發。領先企業對研發的持續投入，以及與醫療機構和研究機構的合作，都為這種不斷改進的承諾提供了支持。這些夥伴關係加深了對使用者需求、偏好和醫療要求的理解，指南新型子宮內避孕器的設計和功能。這種對創新的重視確保了子宮內避孕器始終處於避孕技術的前沿，提供不僅有效，而且兼顧使用者舒適度和健康的選擇。對技術進步的投資凸顯了改善生殖健康的承諾，也是子宮內避孕器市場成長的關鍵驅動力。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球子宮內避孕器（IUD）市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場區隔：依產品分類
  • 市場區隔：依最終用途分類
  • 市場區隔：按地區
  • 市場預測
  • SWOT分析
  • 價值鏈分析
  • 波特五力分析

第6章 市場區隔：依產品分類

  • 釋放荷爾蒙的子宮內避孕器（IUD）
  • 含銅子宮內避孕器

第7章 市場區隔：依最終用途分類

  • 醫院
  • 婦科診所
  • 社區醫療保健
  • 其他

第8章 市場區隔：依地區分類

  • 歐洲
  • 北美洲
  • 亞太地區
  • 中東和非洲
  • 拉丁美洲

第9章：子宮內避孕器（IUD）的製造過程

第10章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Actavis
    • Bayer
    • Teva Pharmaceuticals
    • Allergan
    • ANI Pharmaceuticals
    • Eurogine
    • OCON Medical
    • Pregna
    • SMB Corporation
    • HLL Lifecare
    • HRA Pharma
    • Besins HealthCare
Product Code: SR112026A954

The global intrauterine devices market size reached USD 4.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 6.9 Billion by 2034, exhibiting a growth rate (CAGR) of 3.72% during 2026-2034.The market is propelled by the rising awareness about long-acting reversible contraception (LARC), significant technological advancements in IUD design and insertion techniques, favorable government initiatives promoting family planning and contraception access.

Intrauterine Devices (IUDs) are a form of long-term, reversible birth control, representing one of the most effective contraceptive methods available today. An IUD is a small, T-shaped device that is inserted into the uterus by a healthcare provider to prevent pregnancy. There are two main types of IUDs: copper IUDs, which release a small amount of copper to deter sperm from reaching the egg, and hormonal IUDs, which release hormones to thicken cervical mucus and block sperm from fertilizing the egg. IUDs provide an extended period of protection, ranging from three to ten years, depending on the type. They offer the convenience of minimal ongoing care and are favored for their efficacy, reversibility, and ease of use.

The global market is primarily driven by the increasing awareness about reproductive health facilitated by the availability of effective, long-term contraceptive methods. In line with this, the growing preference for reversible and hassle-free birth control options is also providing an impetus to the market. Moreover, the support and educational initiatives by healthcare providers and organizations about the benefits and usage of IUDs are acting as significant growth-inducing factors for the market. In addition to this, the endorsement of IUDs by medical professionals, owing to their safety and reliability, is encouraging the expansion of the market. Also, the rise in government initiatives promoting family planning and reproductive health education is impacting the market positively. The market is further driven by favorable healthcare policies and insurance coverage, which make IUDs more accessible and affordable to a broader population.

Intrauterine Devices (IUD) Market Trends/Drivers

Rising trend of population control efforts

The growing awareness of sustainable development has led governments and international organizations to prioritize population control efforts. This significant shift in policy direction is reinforcing the role of effective and long-term contraceptive methods such as IUDs. Also, various collaborative programs among governmental bodies of several countries, NGOs, and manufacturers aim to promote IUDs as a preferred method of family planning. These alliances often result in extensive campaigns, distribution networks, and educational outreach, making IUDs more accessible and acceptable to diverse populations. Additionally, tailored interventions and subsidies in various regions further facilitate the adoption of IUDs. This global movement towards population control, with an emphasis on responsible family planning and reproductive choices, stands as a powerful driver for the IUD market, fueling both demand and innovation.

Growing female workforce participation

The rise in the female workforce's participation marks a cultural and economic shift, influencing various aspects of life, including reproductive choices. As women continue to take on professional roles, the need for convenient, reliable, and low-maintenance contraceptive methods has grown. IUDs, known for their extended effectiveness and minimal ongoing care, resonate with the lifestyle needs of working women. They provide the flexibility and assurance that many seek in balancing their careers and personal lives. Moreover, employers and healthcare providers are increasingly recognizing these needs, offering support and coverage for IUDs as part of comprehensive health benefits. This alignment of market supply with the real-life demands of a growing segment of the population is not just a trend but a substantial driving force in the IUD market.

Continual advancements in medical technology and research

The healthcare industry is marked by continuous advancements in medical technology and research, and the field of contraception is no exception. Innovations in materials, designs, and hormone delivery mechanisms have led to the development of more advanced and user-friendly IUDs. The drive for improvement is fueled by investment in research and development by leading companies in the field, often in collaboration with healthcare providers and research institutions. These partnerships enable a deeper understanding of user needs, preferences, and medical requirements, guiding the design and functionality of new IUD models. This focus on innovation ensures that IUDs remain at the forefront of contraceptive technology, offering choices that are not only effective but also aligned with the comfort and well-being of users. The investment in technological progress underscores the commitment to enhancing reproductive health, making it a pivotal driver in the IUD market growth.

Intrauterine Devices (IUD) Industry Segmentation

This report provides an analysis of the key trends in each segment of the market, along with forecasts at the global and regional levels for 2026-2034. The report has categorized the market based on product and end-use.

Breakup by Product

  • Hormonal Intrauterine Device
  • Copper Intrauterine Device

Hormonal intrauterine device (IUD) represents the largest market segment

The demand for hormonal IUDs is growing due to their high effectiveness in preventing pregnancies, which makes them a reliable choice for many. Their suitability for extended usage of up to 3-7 years offers long-term solutions without the need for daily intervention. The ability to return to normal fertility after removal adds to their appeal. Many users also find them to be a preferable non-surgical option, contributing to their popularity. The combined factors of effectiveness, longevity, reversibility, and non-surgical nature make this segment an integral part of the global IUD market.

On the other hand, copper IUDs offer a contraceptive method without the use of hormones, appealing to those who want to avoid hormonal intervention. They provide a cost-effective solution, often entailing only a one-time expense. The protection they offer is long-lasting, often effective for up to 10 years, making them an attractive long-term option. These factors together make copper IUDs a significant segment, reflecting the various preferences and financial considerations of the global population.

Breakup by End-Use

  • Hospitals
  • Gynaecology Clinics
  • Community Healthcare
  • Others

In the hospitals segment, the availability of specialized professionals ensures access to expert care, while the use of modern tools and technologies facilitates insertion. Comprehensive services, including consultation, insertion, and follow-up, create a streamlined patient experience. Hospitals continue to be a core setting for IUD administration, integrating specialized care with state-of-the-art technology to serve a broad population base.

On the other hand, gynaecology clinics are seeing growth in IUD administrations owing to their focused expertise in women's reproductive health. They offer personalized care tailored to individual needs and are often more accessible than hospitals for many patients. This specialized, accessible, and personalized care makes gynaecology clinics an essential part of the landscape, serving a diverse clientele with varying needs and preferences.

Furthermore, community healthcare segment of the market is impelled by the introduction of affordable and often lower-cost services. Accessibility in remote and underserved areas ensures that more people can avail themselves of these devices. Education and outreach are significant components of this segment, with community health providers offering necessary information and support. This approach fosters a wider reach and makes IUDs available to populations that might otherwise have limited access.

Breakup by Region

  • Europe
  • North America
  • Asia Pacific
  • Middle East and Africa
  • Latin America

North America exhibits a clear dominance, accounting for the largest intrauterine devices (IUD) market share

The report has also provided a comprehensive analysis of all the major regional markets, which include Europe, North America, Asia Pacific, Middle East and Africa, and Latin America. According to the report, North America accounted for the largest market share.

The North America region's IUD market is driven by several factors, forming a complex and synergistic landscape that fosters growth. The well-developed healthcare infrastructure ensures robust availability and service delivery, making both hormonal and copper IUDs accessible to a wide range of the population.

Regulatory support in this region fosters a generally favorable environment for IUDs, with clear guidelines and standards that help maintain quality and safety. Economic factors, particularly higher income levels, facilitate more accessible healthcare services, allowing for a broader spectrum of the population to avail themselves of this contraceptive method. These financial considerations also support ongoing research and development in the field, leading to potential innovations and improvements in IUD technology.

The positively changing cultural attitudes towards reproductive health is contributing to a more open dialogue and acceptance of various contraceptive options, including IUDs. The integration of advanced medical practices and continual professional development among healthcare providers further enhances the region's ability to offer state-of-the-art care.

Competitive Landscape

The leading companies are investing in research and development (R&D) activities to create new and improved IUDs. These innovations often focus on enhancing effectiveness, reducing side effects, and increasing user comfort. The key players are also exploring new markets and expanding into emerging economies to utilize opportunities in areas where contraceptive methods like IUDs may be less prevalent. To enhance awareness and acceptance of IUDs, the major companies are engaging in educational campaigns by working with healthcare providers and community organizations to provide accurate product information. Furthermore, the top players are working closely with regulatory bodies to ensure that their products comply with local laws and guidelines, maintaining quality and safety. Apart from this, they are also diversifying their portfolio and offering products at various price points, to make IUDs accessible to a broader range of income levels.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Actavis
  • Bayer
  • Teva Pharmaceuticals
  • Allergan
  • ANI Pharmaceuticals
  • Eurogine
  • OCON Medical
  • Pregna
  • SMB Corporation
  • HLL Lifecare
  • HRA Pharma
  • Besins HealthCare

Key Questions Answered in This Report

1. What was the size of the global intrauterine devices market in 2025?

2. What is the expected growth rate of the global intrauterine devices market during 2026-2034?

3. What are the key factors driving the global intrauterine devices market?

4. What has been the impact of COVID-19 on the global intrauterine devices market?

5. What is the breakup of the global intrauterine devices market based on the product?

6. What are the key regions in the global intrauterine devices market?

7. Who are the key players/companies in the global intrauterine devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Intrauterine Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product
  • 5.5 Market Breakup by End-Use
  • 5.6 Market Breakup by Region
  • 5.7 Market Forecast
  • 5.8 SWOT Analysis
    • 5.8.1 Overview
    • 5.8.2 Strengths
    • 5.8.3 Weaknesses
    • 5.8.4 Opportunities
    • 5.8.5 Threats
  • 5.9 Value Chain Analysis
    • 5.9.1 Overview
    • 5.9.2 Research and Development
    • 5.9.3 Raw Material Procurement
    • 5.9.4 Manufacturing
    • 5.9.5 Marketing
    • 5.9.6 Distribution
    • 5.9.7 End-Use
  • 5.10 Porters Five Forces Analysis
    • 5.10.1 Overview
    • 5.10.2 Bargaining Power of Buyers
    • 5.10.3 Bargaining Power of Suppliers
    • 5.10.4 Degree of Competition
    • 5.10.5 Threat of New Entrants
    • 5.10.6 Threat of Substitutes

6 Market Breakup by Product

  • 6.1 Hormonal Intrauterine Device
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Copper Intrauterine Device
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by End-Use

  • 7.1 Hospitals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Gynaecology Clinics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Community Healthcare
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Region

  • 8.1 Europe
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 North America
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Asia Pacific
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Middle East and Africa
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Latin America
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Intrauterine Devices Manufacturing Process

  • 9.1 Product Overview
  • 9.2 Raw Material Requirements
  • 9.3 Manufacturing Process
  • 9.4 Key Success and Risk Factors

10 Competitive Landscape

  • 10.1 Market Structure
  • 10.2 Key Players
  • 10.3 Profiles of Key Players
    • 10.3.1 Actavis
    • 10.3.2 Bayer
    • 10.3.3 Teva Pharmaceuticals
    • 10.3.4 Allergan
    • 10.3.5 ANI Pharmaceuticals
    • 10.3.6 Eurogine
    • 10.3.7 OCON Medical
    • 10.3.8 Pregna
    • 10.3.9 SMB Corporation
    • 10.3.10 HLL Lifecare
    • 10.3.11 HRA Pharma
    • 10.3.12 Besins HealthCare

List of Figures

  • Figure 1: Global: Intrauterine Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Intrauterine Devices Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Intrauterine Devices Market: Breakup by Product (in %), 2025
  • Figure 4: Global: Intrauterine Devices Market: Breakup by End-Use (in %), 2025
  • Figure 5: Global: Intrauterine Devices Market: Breakup by Region (in %), 2025
  • Figure 6: Global: Intrauterine Devices Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 7: Global: Intrauterine Devices Industry: SWOT Analysis
  • Figure 8: Global: Intrauterine Devices Industry: Value Chain Analysis
  • Figure 9: Global: Intrauterine Devices Industry: Porter's Five Forces Analysis
  • Figure 10: Global: Intrauterine Devices (Hormonal) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Intrauterine Devices (Hormonal) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Intrauterine Devices (Copper) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Intrauterine Devices (Copper) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Intrauterine Devices (End-Use in Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Intrauterine Devices (End-Use in Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Intrauterine Devices (End-Use in Gynaecology Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Intrauterine Devices (End-Use in Gynaecology Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Intrauterine Devices (End-Use in Community Healthcare) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Intrauterine Devices (End-Use in Community Healthcare) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Intrauterine Devices (Other End-Uses) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Intrauterine Devices (Other End-Uses) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Europe: Intrauterine Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Europe: Intrauterine Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: North America: Intrauterine Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: North America: Intrauterine Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Asia Pacific: Intrauterine Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Asia Pacific: Intrauterine Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Middle East and Africa: Intrauterine Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Middle East and Africa: Intrauterine Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Latin America: Intrauterine Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Latin America: Intrauterine Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Intrauterine Devices Manufacturing: Detailed Process Flow

List of Tables

  • Table 1: Global: Intrauterine Devices Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Intrauterine Devices Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Intrauterine Devices Market Forecast: Breakup by End-Use (in Million USD), 2026-2034
  • Table 4: Global: Intrauterine Devices Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 5: Intrauterine Devices Manufacturing: Raw Material Requirements
  • Table 6: Global: Intrauterine Devices Market: Competitive Structure
  • Table 7: Global: Intrauterine Devices Market: Key Players